title: Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
abstract: Although cyclosporin A (CsA) and cortisone acetate (CRT) adversely affect bone, their combined effect on bone is unknown. Sprague Dawley rats were therefore administered either vehicle or CsA (7.5 mg/kg/day) by gavage and saline or CRT (2 mg/100 mg/day) by s.c. injection for 28 days. Group A received vehicle plus saline, group B CsA plus saline, group C vehicle plus CRT, and group D CsA/CRT. Serial bloods were sampled over a 28-day period for ionized calcium (Ca), PTH, 1,25 dihydroxyvitamin D (1,25(OH)2D), and bone gla protein (BGP osteocalcin) and tibia were examined on day 28 for histomorphometry. Results were compared with group A. Ca and PTH levels in groups B, C, and D were similar to those in group A during the study period. Group B had lower body weights, elevated levels of BGP, and an increase in 1,25(OH)2D. Group C developed weight loss and a decrease in BGP and 1,25(OH)2D. Group D had weight loss, BGP levels between those of group A and group C, and 1,25(OH)2D values similar to group A. Bone histomorphometry revealed high turnover osteopenia in group B and hyperostosis in group C with a decrease in bone formation and osteoclastlike cells. Combination therapy returned these to control values. In conclusion, the adverse effects of either CsA or CRT on bone in rats are minimized by combined therapy.
authors.affiliation: Division of Endocrinology and Metabolism, Albert Einstein Medical Center, Philadelphia, PA 19141.
authors.forename: C
authors.initials: C
authors.lastname: Movsowitz
authors.forename: M
authors.initials: M
authors.lastname: Schlosberg
authors.forename: S
authors.initials: S
authors.lastname: Epstein
authors.forename: F
authors.initials: F
authors.lastname: Ismail
authors.forename: M
authors.initials: M
authors.lastname: Fallon
authors.forename: S
authors.initials: S
authors.lastname: Thomas
mesh_terms: D000818:Animals; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000473:pathology; D002452:Cell Count; D003348:Cortisone / Q000031:analogs & derivatives* / Q000494:pharmacology; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000494:pharmacology*; D004100:Dihydroxycholecalciferols / Q000097:blood; D004357:Drug Synergism; D008297:Male; D015675:Osteocalcin / Q000097:blood; D010012:Osteogenesis / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013977:Tibia / Q000033:anatomy & histology / Q000166:cytology / Q000187:drug effects
chemical_list: D003524:Cyclosporins; D004100:Dihydroxycholecalciferols; D015675:Osteocalcin; D003404:Creatinine; D003348:Cortisone